Implications of the South African variant on vaccine efficacy and natural immunity

The speaker discusses the concerns surrounding the South African variant of the coronavirus and its potential impact on vaccine effectiveness and natural immunity. They explain the possible reasons for reduced efficacy and highlight the preliminary in vitro studies conducted by Pfizer and Moderna. The chapter explores the complex interplay between vaccines, social distancing, and the emergence of new coronavirus strains.